original ) (raw )Sialic acid treatment makes cancer cells distinguishable from normal cells
Leyla Djansugurova
View PDFchevron_right
Inhibition of Human Anti-Gd Cold Agglutinins by Sialyllactose
Walter Riesen
Scandinavian Journal of Immunology, 1978
View PDFchevron_right
Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity
Govind Ragupathi
Clinical Cancer Research, 2011
View PDFchevron_right
Early Murine T-lymphocyte Activation Is Accompanied by a Switch from N-Glycolyl- to N-Acetyl-neuraminic Acid and Generation of Ligands for Siglec-E
Aristotelis Antonopoulos
Journal of Biological Chemistry, 2011
View PDFchevron_right
Characterization of Expression of Glycan Ligands for Siglec-F in Normal Mouse Lungs
Bruce Bochner
American Journal of Respiratory Cell and Molecular Biology, 2011
View PDFchevron_right
Altered expression of sialylated carbohydrate antigens in HT29 colonic carcinoma cells
Pi-wan Cheng
Glycoconjugate …, 1998
View PDFchevron_right
Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes
Martin Herrmann
Journal of Cell Science, 2010
View PDFchevron_right
Sialic Acid and Cancer
Philippe Delannoy
Glycoscience: Biology and Medicine, 2014
View PDFchevron_right
Synthesis of a Carbon-Linked Mimic of the Disaccharide Component of the Tumor-Related SialylTn Antigen
zouleika abdallah
2003
View PDFchevron_right
Preferential Lectin Binding of Cancer Cells upon Sialic Acid Treatment Under Nutrient Deprivation
Prof. Dr. Haitham A . Badr , Chen-zhong Li
Applied Biochemistry and Biotechnology Volume 171, Issue 4 , pp 963-974 , 2013
View PDFchevron_right
Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
Jeanette Leusen
Cancers
View PDFchevron_right
Selectin Ligands and Tumor-Associated Carbohydrate Structures: Specificities of .alpha.2,3-Sialyltransferases in the Assembly of 3'-Sialyl-6-sulfo/sialyl Lewis a and x, 3'-Sialyl-6'-sulfo Lewis x, and 3'-Sialyl-6-sialyl/sulfo Blood Group T-hapten
khushi matta
Biochemistry, 1995
View PDFchevron_right
Fukushima, K. et al. Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res. 44, 5279-5285
David Chia
Cancer Research
View PDFchevron_right
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids
Lucio L A R A Santos
Scientific reports, 2018
View PDFchevron_right
Studies on the detection, expression, glycosylation, dimerization and ligand binding properties of mouse Siglec-E
Weiping Jiang
The Journal of biological chemistry, 2016
View PDFchevron_right
Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues
Catarina Gomes
International journal of biological macromolecules, 2018
View PDFchevron_right
Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines
Mina Fogel
Cancer research, 1983
View PDFchevron_right
Glycoprotein CA19.9-specific monoclonal antibodies recognize sialic acid–independent glycotope
Оксана Г
Tumor Biology
View PDFchevron_right
Role of the Human ST6GalNAc-I and ST6GalNAc-II in the Synthesis of the Cancer-Associated Sialyl-Tn Antigen
Andrea Cruz
Cancer Research, 2004
View PDFchevron_right
Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin
Nathan Zaccai
Structure, 2003
View PDFchevron_right
Human B-lymphocytes Express 2-6-Sialylated 6-Sulfo-N-acetyllactosamine Serving as a Preferred Ligand for CD22/Siglec-2
Akihiko Moriyama
Journal of Biological Chemistry, 2007
View PDFchevron_right
Sialic acid‐binding immunoglobulin‐like lectin (Sigelac)‐15 is a rapidly internalised cell‐surface antigen expressed by acute myeloid leukaemia cells
Bernard de Bono
British Journal of Haematology, 2021
View PDFchevron_right
Sialic acid‐binding immunoglobulin‐like lectin (Siglec)‐15 is a rapidly internalised cell‐surface antigen expressed by acute myeloid leukaemia cells
Bernard de Bono
British Journal of Haematology, 2021
View PDFchevron_right
Distinct sub-populations of carcinoma-associated MUC1 mucins as detected by the monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast-cancer patients
Rein Sikut
International Journal of Cancer, 1996
View PDFchevron_right
Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells
Gerard Donohoe
Drug Discovery Today, 2007
View PDFchevron_right
Lectin staining and Western blot data showing differential sialylation of nutrient-deprived cancer cells to sialic acid supplementation
Dina Alsadek
Data in Brief, 2015
View PDFchevron_right
Human Xeno-Autoantibodies against a Non-Human Sialic Acid Serve as Novel Serum Biomarkers and Immunotherapeutics in Cancer
Saddam Muthana
Cancer Research, 2011
View PDFchevron_right
Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system
Fujiro Sendo
International Journal of Cancer, 1984
View PDFchevron_right
Modification of sialidase levels and sialoglycoconjugate pattern during erythroid and erytroleukemic cell differentiation
Nadia Papini
Glycoconjugate Journal, 2006
View PDFchevron_right
Characterization of Siglec-5 (CD170) expression and functional activity of anti–Siglec-5 antibodies on human phagocytes
Andrew King
Experimental Hematology, 2003
View PDFchevron_right